Patents by Inventor Martin Hoffer

Martin Hoffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220233579
    Abstract: The invention provides a hydrogen sulfide releasing polymer compound having a polysaccharide backbone, wherein the compound has at least two substructures, and wherein said substructures are capable of releasing hydrogen sulfide by thiol activation as well as uses thereof. Additionally, a method of treatment and prevention of a skin condition, an ocular disease or osteoarthritis is provided.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Inventors: Martin PRINZ, Martin HOFFER
  • Patent number: 11331338
    Abstract: The invention provides a hydrogen sulfide releasing polymer compound having a polysaccharide backbone, wherein the compound has at least two substructures, and wherein said substructures are capable of releasing hydrogen sulfide by thiol activation as well as uses thereof. Additionally, a method of treatment and prevention of a skin condition, an ocular disease or osteoarthritis is provided.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: May 17, 2022
    Assignee: CROMA-PHARMA GESELLSCHAFT M.B.H.
    Inventors: Martin Prinz, Martin Hoffer
  • Publication number: 20190298756
    Abstract: The invention provides a hydrogen sulfide releasing polymer compound having a polysaccharide backbone, wherein the compound has at least two substructures, and wherein said substructures are capable of releasing hydrogen sulfide by thiol activation as well as uses thereof. Additionally, a method of treatment and prevention of a skin condition, an ocular disease or osteoarthritis is provided.
    Type: Application
    Filed: November 7, 2017
    Publication date: October 3, 2019
    Inventors: Martin PRINZ, Martin HOFFER
  • Publication number: 20080200563
    Abstract: The non-invasive administration of many active ingredients fails with efflux pumps which sharply reduce the active ingredient absorption on mucous membranes. According to the invention, the active ingredient absorption on mucous membranes can be drastically improved by using dosages containing glutathione and/or compounds comprising numerous thiol groups, in addition to the active ingredient(s). Forms of administration such as matrix tablets, capsules, eye drops, or microparticles, containing the cited combination of active ingredients and auxiliary substances, can be used.
    Type: Application
    Filed: July 14, 2005
    Publication date: August 21, 2008
    Applicants: ThioMatrix Forschungs- und Beratungs- GmbH, MucoBiomer Biotechnologische Forschungs- und Entwicklungs- GmbH
    Inventor: Martin Hoffer